当前位置:首页 - 行情中心 - 佐力药业(300181) - 财务分析

佐力药业

(300181)

  

流通市值:77.53亿  总市值:90.20亿
流通股本:6.03亿   总股本:7.01亿

佐力药业(300181)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.02亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益349336.17万元,未分配利润120100.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产533070.34万元,负债183734.16万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入897,797,296.943,040,763,497.872,279,713,382.851,599,453,446.18
营业总成本674,900,714.952,370,426,574.041,720,477,214.141,184,629,333.23
其他经营收益
营业利润237,996,923.07766,929,828.88617,741,588.5451,582,737.74
利润总额237,607,239.7755,667,884.66610,760,250.3447,894,777.16
净利润202,011,621.75642,436,652.8518,111,660.82379,193,091.62
每股收益
其他综合收益38,704,464.72104,850,057.77193,161,979.42266,901,782.73
综合收益总额240,716,086.47747,286,710.57711,273,640.24646,094,874.35
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,598,075,424.912,391,301,974.432,380,977,141.982,298,188,032.45
非流动资产:
非流动资产合计2,732,627,933.982,320,368,925.152,262,328,465.382,301,207,601.31
资产总计5,330,703,358.894,711,670,899.584,643,305,607.364,599,395,633.76
流动负债:
流动负债合计1,674,897,758.771,338,957,055.951,278,802,587.111,265,310,381.53
非流动负债:
非流动负债合计162,443,871.24131,383,541.45181,804,469.12227,222,846.97
负债合计1,837,341,630.011,470,340,597.41,460,607,056.231,492,533,228.5
所有者权益(或股东权益):
归属于母公司股东权益合计3,424,388,588.243,180,077,388.973,117,125,872.983,038,206,441.68
股东权益合计3,493,361,728.883,241,330,302.183,182,698,551.133,106,862,405.26
负债和股东权益合计5,330,703,358.894,711,670,899.584,643,305,607.364,599,395,633.76
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计809,560,228.463,111,354,396.32,217,743,303.911,549,438,051.75
经营活动现金流出小计729,552,782.12,699,552,661.381,951,741,862.191,259,854,039.72
经营活动产生的现金流量净额80,007,446.36411,801,734.92266,001,441.72289,584,012.03
投资活动产生的现金流量:
投资活动现金流入小计9,279.433,322,978.586,073,5986,016,998
投资活动现金流出小计103,830,292.55414,575,320.97235,959,253.8172,353,433.32
投资活动产生的现金流量净额-103,821,013.12-411,252,342.39-229,885,655.8-166,336,435.32
筹资活动产生的现金流量:
筹资活动现金流入小计242,018,654883,895,750733,114,250540,300,750
筹资活动现金流出小计170,926,460.921,001,104,624.14876,194,801.29716,195,863.87
筹资活动产生的现金流量净额71,092,193.08-117,208,874.14-143,080,551.29-175,895,113.87
汇率变动对现金及现金等价物的影响-63.35-144.48-96.54-103.54
现金及现金等价物净增加额47,278,562.97-116,659,626.09-106,964,861.91-52,647,640.7
期末现金及现金等价物余额706,173,990.02658,895,427.05668,590,191.23722,907,412.44
补充资料:
现金及现金等价物的净增加额--116,659,626.09--52,647,640.7
最新报告期:2026-05-24
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长江证券张楠,彭英骐1.161.441.712026-05-24
中信证券宋硕,陈竹1.041.261.502026-05-15
长城证券刘鹏,袁紫馨1.151.391.672026-05-12
中邮证券盛丽华,龙永茂1.131.421.732026-05-07
东吴证券向潇,朱国广1.181.471.702026-04-30
TOP↑